Acromegaly is a rare disease associated with comorbidities that are common in the general
population. Most patients undergo screening for classic phenotypical (CP) or mass effect …

Background Traditionally, acromegaly evaded diagnosis until in its clinically obvious later
stages when treatment is more difficult. Over the last 25 years diagnostic tests have …

Purpose We investigated whether acromegaly has been diagnosed earlier at the Niigata
Medical and Dental University Hospital. Methods Patients with acromegaly (n= 81) who …

AIMS OF THE STUDY Acromegaly due to a growth hormone-secreting pituitary adenoma is
a rare disease with high morbidity if not treated adequately. Using data of the Swiss Pituitary …

Purpose Approximately 25% of cases of clinically active acromegaly cases treated in our
academic center between 1996 and 2000, were diagnosed in patients who had elevated …

Background To examine the clinical and hormonal profiles, comorbidities, treatment
patterns, surgical pathology and clinical outcomes of patients diagnosed with acromegaly at …

Context The term micromegaly has been used to describe a subset of patients who have
elevated IGF-1 levels but apparently normal basal GH (bGH) concentrations and often a …

Acromegaly is a rare disorder caused by chronic growth hormone (GH) hypersecretion.
While diagnostic and therapeutic methods have advanced, little information exists on trends …

Context: GH-secreting pituitary adenomas are nearly always visible on conventional
magnetic resonance (MR) imaging. However, management and outcome of acromegalic …

Objective Acromegaly, a disease caused by GH/IGF‐I hypersecretion, is associated with a
high mortality rate; early recognition is therefore necessary to ensure successful treatment …